A Phase 1 Study of the Safety and Tolerability of CTX-10726
Compass Therapeutics
Compass Therapeutics
GlaxoSmithKline
Hospital Universitari de Bellvitge
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Rutgers, The State University of New Jersey
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France